STOCK TITAN

CNTA (NASDAQ: CNTA) insider files Form 144 to sell 120,029 ADRs valued $3.10M

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

CNTA reports a proposed sale of ADRs under Form 144. The filing lists 120,029 ADRs with an aggregate value of $3,103,949.94 and a filing date of 03/13/2026. The notice shows securities tied to an exercise of stock options (109,398 ADRs) on 03/13/2026 and vested RSUs (10,631 ADRs) dated 02/01/2026.

The broker/dealer named is UBS Financial Services Inc. in Weehawken, NJ, and the ADRs are traded on Nasdaq. This Form 144 is a regulatory notice of an intended sale; timing and final execution are determined by the selling holder and market conditions.

Positive

  • None.

Negative

  • None.

Insights

Form 144 lists a planned sale of 120,029 ADRs valued at $3.10M; proceeds treatment and timing are not set here.

The filing shows 120,029 ADRs with an aggregate value of $3,103,949.94 and identifies an exercise of stock options for 109,398 ADRs dated 03/13/2026. The notice names UBS Financial Services Inc. as the broker/dealer.

Execution depends on holder decisions and market execution; subsequent filings or trade reports would confirm realized sales and proceeds allocation.

This is a routine insider resale notice showing option-derived and RSU-derived ADRs, with no new corporate action disclosed.

The filing enumerates 10,631 ADRs from vested RSUs dated 02/01/2026 and lists Nasdaq as the trading market. There is no internal governance change or transaction condition disclosed in the excerpt.

Impact depends on whether and when the holder sells; the Form 144 itself is an intended-sale disclosure rather than evidence of completed trades.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does CNTA's Form 144 report?

The Form 144 reports a proposed sale of ADRs by a holder, listing 120,029 ADRs valued at $3,103,949.94. It details 109,398 ADRs from an option exercise dated 03/13/2026 and 10,631 ADRs from vested RSUs dated 02/01/2026.

Who is the broker/dealer listed on the CNTA Form 144?

The filing names UBS Financial Services Inc. located at 1000 Harbor Blvd, Weehawken, NJ. The broker/dealer is the intermediary shown on the notice for the intended sale of ADRs.

Are the ADRs subject to sale already sold?

No; Form 144 is a regulatory notice of an intended sale and does not confirm execution. It lists the proposed 120,029 ADRs and dates, but actual sale reports would appear in trade records or subsequent filings.

What types of securities are being disposed of in the CNTA filing?

The document lists ADRs arising from an exercise of stock options (109,398 ADRs) and from vested RSUs (10,631 ADRs). Both source types are explicitly dated in the filing.
Centessa Pharmaceuticals Plc

NASDAQ:CNTA

View CNTA Stock Overview

CNTA Rankings

CNTA Latest News

CNTA Latest SEC Filings

CNTA Stock Data

4.02B
134.77M
Biotechnology
Pharmaceutical Preparations
Link
United Kingdom
ALTRINCHAM, CHESHIRE